Inactive Instrument

Highlights PONO CAPI

Equities

PONO

US7324501011

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Japan startup selling $550,000 Star Wars-inspired hoverbike to list on NASDAQ	03/23/03	RE
AERWINS Technologies Inc. completed the acquisition of Pono Capital Corp. from Mehana Equity LLC and others in a reverse merger transaction.	03/23/03	CI
PONO CAPITAL CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	14/22/14	AQ
Pono Capital Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/22/14	CI
AERWINS Technologies Inc. signed a definitive Agreement and plan of merger to acquire Pono Capital Corp. from Mehana Equity LLC and others for $610 million in a reverse merger transaction.	07/22/07	CI
PONO CAPITAL CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	13/22/13	AQ
Pono Capital Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	13/22/13	CI
Pono Capital Nixes SPAC Merger Deal With Drug Developer Benuvia	11/22/11	MT
Pono Capital : Announces Termination of Merger Agreement with Benuvia, Inc - Form 8-K	11/22/11	PU
Pono Capital Corp Announces Termination of Merger Agreement with Benuvia, Inc.	11/22/11	AQ
Benuvia Therapeutics Inc. cancelled the acquisition of Pono Capital Corp. from Mehana Equity LLC and others in a reverse merger transaction.	08/22/08	CI
PONO CAPITAL CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	13/22/13	AQ
Pono Capital Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	13/22/13	CI
Pono Capital Corp. Reports Earnings Results for the Eleven Months Ended December 31, 2021	26/22/26	CI
Cannabinoid Drugmaker Benuvia to Go Public Via SPAC Merger With Pono Capital	18/22/18	MT
Pono Capital : Benuvia, a Leading Drug Developer Focused on Pharmaceutical Cannabinoids, with the FDA Approved Drug SYNDROS®, Signs Definitive Agreement to Become a Publicly Traded Company through a - Form 8-K	18/22/18	PU
Benuvia Therapeutics Inc. entered into an agreement to acquire Pono Capital Corp. from Mehana Equity LLC and others for approximately $400 million in a reverse merger transaction.	18/22/18	CI
Pono Capital Corp. has completed an IPO in the amount of $100 million.	10/21/10	CI
Pono Capital Corp. has filed an IPO in the amount of $100 million.	16/21/16	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW